Case 2:13-cv-00391-ES-JAD Document 386 Filed 08/31/17 Page 1 of 2 PageID: 7625
`
`Case 2:13-cv-00391-ES-JAD Document 386 Filed 08/31/17 Page 1 of 2 PagelD: 7625
`
`Charles M. Lizza
`
`Phone:
`
`(973)286-6715
`
`Fax:
`
`(973)286-6815
`
`clizzalé‘saulxom
`www.saul.com
`
`August 30, 2017
`
`
`
`VIA ECF
`
`The Honorable Joseph A. Dickson, U.S.M.J.
`United States District Court
`
`Martin Luther King, Jr. Federal Building
`50 Walnut Street
`
`Newark, New Jersey 07102
`
`Q:
`
`Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC, et al.
`Civil Action No. 13-391 [ES )1 JAD)
`
`Dear Judge Dickson:
`
`This firm, together with Quinn Emanuel Urquhart & Sullivan, LLP and Richard G. Greco
`PC, represents plaintiffs Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited
`(collectively, “Jazz”) in the above-captioned action. We write on behalf of all parties.
`
`The parties have been working diligently to complete fact discovery. Nevertheless,
`because of the number of parties involved and the remaining outstanding discovery issues, the
`parties believe that some additional time will be necessary to complete fact discovery and,
`ultimately, prepare this case for trial. Accordingly, the parties have agreed, subject to Your
`Honor’s approval, to the following modifications to the current case schedule:
`
`
`
`
`-
`
`.. Bli‘o' éfiéfl-Reflséd Mtge
`Setember 26, 2017
`
`November 7, 2017
`
`
`.
`
`
`'t_-
`Close of Fact Discovery
`
`O enin; Ex ert Re oorts
`
`2
`
`out _" . :1 Date
`Au_ st 18, 2017
`Se tember 29, 2017
`
`l The parties agree that, if the Court does not issue a Markman decision by September 29, 2017, then they will meet
`and confer to submit a joint proposal (if an agreement can be reached), or competing proposals (if no agreement can
`be reached), to the Court concerning an appropriate extension of expert discovery deadlines by October 6, 2017. Par
`also wishes to note that it has filed a motion to compel discovery of documents and things from third party Express
`Scripts Specialty Distribution Services, Inc. (“Express Scripts”) in the United States District Court for the Eastern
`District of Missouri, and that the information Par is seeking from Express Scripts is relevant to its opening expert
`reports. See Par Pharmaceutical, Inc. v. Express Scripts Specialty Distribution Services, Inc., No. 4: 17-mc-5 10
`(ED. Mo. Aug. 25, 2017). To the extent that the court has not resolved that motion by the scheduled date for
`opening expert reports, or the Court has resolved that motion in Par’s favor but Express Scripts has not produced the
`responsive documents in sufficient time for Par to address such documents and things in Par’s opening expert report,
`
`One Riverfront Plaza, Suite 1520 Newark, NJ 07102-5426 Phone: (973) 286-6700 Fax: (973) 286-6800
`
`
`

`

`Case 2:13-cv-00391-ES-JAD Document 386 Filed 08/31/17 Page 2 of 2 PageID: 7626
`
`Case 2:13-cv-00391-ES—JAD Document 386 Filed 08/31/17 Page 2 of 2 PagelD: 7626
`
`Hon. Joseph A. Dickson, U.S.M.J.
`August 30, 2017
`Page 2
`
`Rebuttal Exort Roorts
`Rel Exert Ro-orts
`
`
`
`
`
`Close of Ex ort Discovery
`Dis ositivo Motions __
`Pretrial Submissions
`48 hours before Pretrial
`48 hours before Pretrial
`
`
`
`
`
`
`
`
`
`
`
`Pretrial Conference _—
`
`Trial
`TBD
`
`
`
`
`
`
`The parties’ agreed-upon schedule will result in only a little more than a one-month
`overall extension of the schedule, which we believe is reasonable in light of the numerous
`complex issues involved. If this schedule meets with Your Honor’s approval, the parties
`respectfully request that Your Honor sign the below form of endorsement and have it entered on
`the docket.
`
`Thank you for Your Honor’s kind attention to this matter.
`
`Respectfully yours,
`
`Charles M. Lizza
`
`cc:
`
`All Counsel (via e-mail)
`51‘
`
`so ORDERED on this 3L day of fin/11., 2017:
`
`Hon. JésephiA. Dickson, U.S.M.J.
`
`xx
`
`Par may seek leave of the Court to submit a supplemental expert report solely addressing information produced by
`Express Scripts.
`
`